USD 3.96
(2.06%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
Operating Cash Flow | 4.98 Billion | 8.33 Billion | 2.24 Billion | 6.96 Billion | 5.04 Billion | 1.44 Billion |
Net Income | 48.93 Million | 674.52 Million | 1.25 Billion | 1.53 Billion | 705.37 Million | 1.06 Billion |
Depreciation & Amortization | 4.77 Billion | 3.97 Billion | 3.29 Billion | 2.83 Billion | 2.29 Billion | 1.53 Billion |
Deferred income taxes | 183.1 Million | 346.49 Million | 590.26 Million | 68.41 Million | 314.33 Million | 2.61 Million |
Stock-based compensation | 6.87 Million | 16.49 Million | 22.88 Million | 40.05 Million | 46.37 Million | 4.83 Million |
Change in working capital | -1.01 Billion | 2.94 Billion | -3.08 Billion | 1.04 Billion | -15.47 Million | -1.89 Billion |
Other non-cash items | 1.93 Billion | 383.59 Million | 163.02 Million | 1.44 Billion | 1.7 Billion | 730.07 Million |
Investing Cash Flow | -12.26 Billion | -13.59 Billion | -7.59 Billion | -3.61 Billion | -4.32 Billion | -3.97 Billion |
Investments in PPE | -12.37 Billion | -13.21 Billion | -7.37 Billion | -3.75 Billion | -4.5 Billion | -3.96 Billion |
Acquisitions | - | - | - | - | - | - |
Investment purchases | -153.64 Million | -546.88 Million | -263.9 Million | -5.51 Million | - | -38.3 Million |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | -1.14 Billion | 166.53 Million | 45 Million | 142.93 Million | 175.25 Million | 33.46 Million |
Financing Cash Flow | 7.44 Billion | 4.94 Billion | 4.16 Billion | 618.37 Million | 3.92 Million | 3.05 Billion |
Debt repayment | -10.25 Billion | -265.23 Million | -316.59 Million | -226.15 Million | -219.52 Million | -89.08 Million |
Dividends payments | - | - | - | - | -223.6 Million | -217.88 Million |
Common Stock Repurchased | - | - | - | - | - | 3.13 Billion |
Common Stock Issuance | - | - | - | - | - | 935.44 Million |
Other Financing Activities | -2.8 Billion | 5.2 Billion | 4.48 Billion | 844.52 Million | 447.05 Million | -707.93 Million |
Accounts receivables | -481.26 Million | -400.48 Million | -4.08 Billion | 1.07 Billion | -289.83 Million | -2.18 Billion |
Accounts payables | - | 2.05 Billion | - | 201.4 Million | -308.18 Million | 1.06 Billion |
Inventory | -1.45 Billion | 465.28 Million | -992.46 Million | -112.68 Million | 413.25 Million | -1.06 Billion |
Other working capital | 829.31 Million | 827.96 Million | 1.98 Billion | -118.07 Million | 169.28 Million | 283.65 Million |
Cash at beginning of period | 3.89 Billion | 4.2 Billion | 5.37 Billion | 1.41 Billion | 694.77 Million | 166.58 Million |
Cash at end of period | 4.05 Billion | 3.89 Billion | 4.2 Billion | 5.37 Billion | 1.41 Billion | 694.77 Million |
Capital Expenditure | -12.37 Billion | -13.21 Billion | -7.37 Billion | -3.75 Billion | -4.5 Billion | -3.96 Billion |
Effect of forex changes on cash | 1.23 Million | 1.31 Million | 2.36 Million | -3.37 Million | 100 Thousand | 6.1 Million |
Net cash flow / Change in cash | 165.31 Million | -308.28 Million | -1.17 Billion | 3.96 Billion | 720.52 Million | 528.18 Million |
Free Cash Flow | -7.39 Billion | -4.87 Billion | -5.12 Billion | 3.21 Billion | 541.24 Million | -2.52 Billion |
Breakdown | 2024 FY | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 48.93 Million | 38.08 Million | -14 Million | -40.01 Million | 64.86 Million | 33.83 Million |
Depreciation & Amortization | 4.77 Billion | - | 14.2 Million | 14.67 Million | 13.6 Million | 13.28 Million |
Deferred income taxes | 183.1 Million | - | - | - | - | - |
Stock-based compensation | 6.87 Million | 1.54 Million | - | 2.63 Million | 2.7 Million | 8.25 Million |
Change in working capital | -1.01 Billion | - | - | - | - | - |
Other non-cash items | 1.93 Billion | -39.62 Million | 14 Million | 37.38 Million | -67.56 Million | -42.08 Million |
Investing Cash Flow | -12.26 Billion | - | - | - | - | - |
Investments in PPE | -12.37 Billion | - | - | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | -153.64 Million | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | -1.14 Billion | - | - | - | - | - |
Financing Cash Flow | 7.44 Billion | - | - | - | - | - |
Debt repayment | -10.25 Billion | - | - | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -2.8 Billion | - | - | - | - | - |
Accounts receivables | -481.26 Million | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | -1.45 Billion | - | - | - | - | - |
Other working capital | 829.31 Million | - | - | - | - | - |
Cash at beginning of period | 3.89 Billion | - | 91.15 Million | 61.8 Million | 58.95 Million | 32.38 Million |
Cash at end of period | 4.05 Billion | - | 119.57 Million | 91.15 Million | 86.16 Million | 58.95 Million |
Capital Expenditure | -12.37 Billion | - | - | - | - | - |
Effect of forex changes on cash | 1.23 Million | - | - | - | - | - |
Net cash flow / Change in cash | 165.31 Million | - | 28.41 Million | 29.34 Million | 27.2 Million | 26.57 Million |
Free Cash Flow | -7.39 Billion | - | 28.41 Million | 29.34 Million | 27.2 Million | 26.57 Million |
4631
9548
ARE
XBIO
CABJF
SMIT